Seelaus Asset Management’s Gilead Sciences GILD Stock Holding History

Seelaus Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,138	Closed	-$215K	–	180
2024 Q2	$215K	Buy	+3,138	New	+$209K	0.22%	142
2023 Q2	–	Sell	-2,723	Closed	-$228K	–	204
2023 Q1	$228K	Buy	2,723 +3	+0.1%	+$248	0.17%	164
2022 Q4	$234K	Buy	+2,720	New	+$215K	0.18%	166
2021 Q4	–	Sell	-9,110	Closed	-$636K	–	281
2021 Q3	$636K	Buy	9,110 +425	+5%	+$29.9K	0.37%	80
2021 Q2	$598K	Buy	8,685 +735	+9%	+$49.1K	0.35%	88
2021 Q1	$514K	Buy	7,950 +335	+4%	+$21.6K	0.33%	97
2020 Q4	$444K	Sell	7,615 -235	-3%	-$14.2K	0.32%	92
2020 Q3	$496K	Buy	+7,850	New	+$544K	0.4%	74
2018 Q2	–	Sell	-2,830	Closed	-$213K	–	183
2018 Q1	$213K	Buy	2,830 +30	+1%	+$2.38K	0.18%	148
2017 Q4	$201K	Buy	+2,800	New	+$213K	0.17%	164

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Seelaus Asset Management's GILD Position: Q3 2024 in Review

Seelaus Asset Management sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 3,138 shares — an estimated $215K sold.

Seelaus Asset Management first reported a position in GILD in Q4 2017 and held it in 10 quarters. The position peaked at $636K in Q3 2021. 1,719 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

Seelaus Asset Management reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
Seelaus Asset Management sold 3,138 Gilead Sciences shares in Q3 2024, an estimated $215K.
Seelaus Asset Management first reported a position in Gilead Sciences in Q4 2017 and held it in 10 quarters.
Seelaus Asset Management's Gilead Sciences position peaked at $636K in Q3 2021.
1,719 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Seelaus Asset Management's 13F filing for Q3 2024, filed 6 Nov 2024.